How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,818 results for

Congenital Heart Disease Imaging in Adults

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Hypothyroidism With Congenital Heart Disease (CHD)

. According to the Italian Registry of Congenital Hypothyroidism, congenital heart disease is the most frequent disease condition associated with congenital hypothyroidism. Congenital heart disease is also reported to be a risk factor for non-autoimmune hypothyroidism in children. In addition, intravenous iodine contrast media is frequently used for diagnostic imaging and therapeutic intervention in congenital heart disease patients. Excess iodine exposed by iodine contrast media may disturb thyroid (...) function in adult and pediatric population. However, there is no generally accepted guideline for screening thyroid dysfunction in congenital heart disease infants. An increased prevalence of thyroid disease, particularly sub-clinical hypothyroidism, has been reported in Down Syndrome. In children with Down Syndrome, a possible concomitant sub-clinical hypothyroidism-related impairment of cardiac function or structure may worsen their clinical condition and can ultimately affect their life expectancy

2018 Clinical Trials

42. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association (Full text)

with Fontan circulation, and this population is expected to double in the next 20 years. In the absence of a subpulmonary ventricle, Fontan circulation is characterized by chronically elevated systemic venous pressures and decreased cardiac output. The addition of this acquired abnormal circulation to innate abnormalities associated with single-ventricle congenital heart disease exposes these patients to a variety of complications. Circulatory failure, ventricular dysfunction, atrioventricular valve (...) for these patients requires coordinated input from pediatric and adult congenital cardiologists, as well as multiple subspecialists, many of whom are not familiar with the physiology or the end-organ consequences of the Fontan circulation. A focused effort to increase our knowledge about patients surviving single-ventricle palliative surgeries is therefore critically important at this time. In a synthesis of the best current evidence and expertise into a single unified source, this American Heart Association

2019 American Heart Association PubMed abstract

43. Integrated Computational modelIng of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease

. The improvement in survival of CHD patients has led to burgeoning numbers of grown-up CHD.The majority of these CHD patients face a lifetime of problems including RV dilation, ventricular arrhythmias, and sudden cardiac death.Considering inflation to visit costs and added image technology for diagnosis, the cost of each patient is expected to increase .In contrast to adult patients with acquired heart disease, abnormalities of the RV are ubiquitous in children and adults with CHD. Currently, clinical (...) Integrated Computational modelIng of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease Integrated Computational modelIng of Right Heart Mechanics and Blood Flow Dynamics in Congenital Heart Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2017 Clinical Trials

44. Current Interventional and Surgical Management of Congenital Heart Disease: Specific Focus on Valvular Disease and Cardiac Arrhythmias. (Full text)

Current Interventional and Surgical Management of Congenital Heart Disease: Specific Focus on Valvular Disease and Cardiac Arrhythmias. Successful outcome in the care of patients with congenital heart disease depends on a comprehensive multidisciplinary team. Surgery is offered for almost every heart defect, despite complexity. Early mortality for cardiac surgery in the neonatal period is ≈10% and beyond infancy is <5%, with 90% to 95% of patients surviving with a good quality of life (...) into the adult years. Advances in imaging have facilitated accurate diagnosis and planning of interventions and surgical procedures. Similarly, advances in the perioperative medical management of patients, particularly with intensive care, has also contributed to improving outcomes. Arrhythmias and heart failure are the most common late complications for the majority of defects, and reoperation for valvar problems is common. Lifelong surveillance for monitoring of recurrent or residual structural heart

2017 Circulation Research PubMed abstract

45. Stable ischaemic heart disease

has no competing interests. Director Section of Transcatheter Treatment of Congenital Heart Disease in the Adult Rovigo General Hospital Rovigo Italy Disclosures GR declares that he has no competing interests. Use of this content is subject to our Services Legal © BMJ Publishing Group 2018 ISSN 2515-9615 Help us improve Thank you × Your feedback has been submitted successfully. (...) inactivity obesity family history of premature ischaemic heart disease illicit drug use male sex mental stress/depression plasma biomarkers polluted air Diagnostic investigations resting ECG haemoglobin fasting lipid profile fasting blood glucose or HbA1c thyroid-stimulating hormone stress exercise ECG without imaging stress single photon emission computed tomography (SPECT), stress echocardiography, stress cardiac magnetic resonance (CMR), stress positron emission tomography (PET) cardiac computed

2018 BMJ Best Practice

46. Cardiac arrhythmias in coronary heart disease

Cardiac arrhythmias in coronary heart disease SIGN 152 • Cardiac arrhythmias in coronary heart disease A national clinical guideline September 2018 www.healthcareimprovementscotland.org Edinburgh Office | Gyle Square |1 South Gyle Crescent | Edinburgh | EH12 9EB Telephone 0131 623 4300 Fax 0131 623 4299 Glasgow Office | Delta House | 50 West Nile Street | Glasgow | G1 2NP Telephone 0141 225 6999 Fax 0141 248 3776 The Healthcare Environment Inspectorate, the Scottish Health Council, the Scottish (...) arrhythmias in coronary heart disease A national clinical guideline September 2018Scottish Intercollegiate Guidelines Network Gyle Square, 1 South Gyle Crescent Edinburgh EH12 9EB www.sign.ac.uk First published September 2018 ISBN 978 1 909103 53 5 Citation text Scottish Intercollegiate Guidelines Network (SIGN). Cardiac arrhythmias in coronary heart disease. Edinburgh: SIGN; 2018. (SIGN publication no. 152). [September 2018]. Available from URL: http://www.sign.ac.uk SIGN consents to the photocopying

2018 SIGN

47. Stable ischaemic heart disease

has no competing interests. Director Section of Transcatheter Treatment of Congenital Heart Disease in the Adult Rovigo General Hospital Rovigo Italy Disclosures GR declares that he has no competing interests. Use of this content is subject to our Services Legal © BMJ Publishing Group 2018 ISSN 2515-9615 Help us improve Thank you × Your feedback has been submitted successfully. (...) inactivity obesity family history of premature ischaemic heart disease illicit drug use male sex mental stress/depression plasma biomarkers polluted air Diagnostic investigations resting ECG haemoglobin fasting lipid profile fasting blood glucose or HbA1c thyroid-stimulating hormone stress exercise ECG without imaging stress single photon emission computed tomography (SPECT), stress echocardiography, stress cardiac magnetic resonance (CMR), stress positron emission tomography (PET) cardiac computed

2018 BMJ Best Practice

48. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association (Full text)

of adults with congenital heart disease adds to management complexity and emphasizes the need for coordinated care by adult congenital cardiovascular specialists. Disorders of Heart Rhythm (Chapter 17) • The frequency and adverse consequences of clini- cally unrecognized and asymptomatic atrial fibrilla- tion (AF) are increasingly reported, particularly in older adults. For instance, in a community-based study in Sweden, >7000 people 75 to 76 years of age were monitored intermittently; 3% had newly (...) . . . . . . . . . . . . . . . . . e295 11. Metabolic Syndrome . . . . . . . . . . . . . . . e313 12. Chronic Kidney Disease . . . . . . . . . . . . . e336 Cardiovascular Conditions/Diseases 13. Total Cardiovascular Diseases . . . . . . . . . . e349 14. Stroke (Cerebrovascular Disease). . . . . . . . . e374 15. Global CVD and Stroke . . . . . . . . . . . . . . e414 16. Congenital Cardiovascular Defects and Kawasaki Disease . . . . . . . . . . . . . . . . e423 17. Disorders of Heart Rhythm . . . . . . . . . . . . e440 18. Sudden

2017 American Heart Association PubMed abstract

49. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines CLINICAL STATEMENTS AND GUIDELINES Circulation. 2017;135:e1159–e1195. DOI: 10.1161/CIR.0000000000000503 June 20/27, 2017 e1159 WRITING GROUP MEMBERS* Rick A. Nishimura, MD, MACC, FAHA, Co-Chair Catherine M. Otto, MD, FACC, FAHA, Co-Chair Robert O. Bonow, MD, MACC (...) and Interventions, Society of Cardio- vascular Anesthesiologists, and Society of Thoracic Surgeons 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines © 2017 by the American Heart Association, Inc., and the American College of Cardiology Foundation. Key Words: AHA Scientific Statements ? anticoagulation therapy ? aortic stenosis

2017 American Heart Association

50. A novel method for evaluating regional RV function in the adult congenital heart with low-dose CT and SQUEEZ processing. (Full text)

A novel method for evaluating regional RV function in the adult congenital heart with low-dose CT and SQUEEZ processing. Measuring local RV function in adult congenital heart disease (ACHD) with echocardiography or MRI is challenging because of the complex geometry and existing pacing devices. Visual assessment of ventricular function via low-dose cardiac CT has been recently performed. This pilot study assessed whether low-dose 4D cine CT combined with automatic measurement of regional (...) shortening could quantify right-ventricular function in ACHD patients.Seven patients with Tetralogy of Fallot either contraindicated for MRI or assessed for coronary artery disease and seven non-congenital patients were imaged with ECG-gated cardiac CT utilizing a 320-detector row scanner. Right ventricular global function and regional shortening were quantified.Non-congenital patients were imaged with 2.9±2.1mSv and 395±359 HU blood-myocardium contrast. The ACHD patients were imaged with 2.1±1.3mSv

2017 International journal of cardiology PubMed abstract

51. Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease

Prevention and Treatment of Thrombi 2680 15.Nursing Considerations in the Identification and Treatment of Thrombi in Infants and Children 2682 16.Special Circumstances Related to Thromboprophylaxis2683 16.1.Air Travel, Immobilization 2683 16.2.Oral Contraceptives 2683 16.3.Pregnancy 2683 16.4.Obesity 2683 16.5.Children and Adults With Developmental Delay 2683 1. Introduction Thrombosis has long been recognized as a potentially life-threatening complication in children with congenital heart disease (CHD (...) for this writing group was to critically review and summarize the available data on thrombosis in this patient population and to make recommendations when appropriate. The anticipated readership is the multidisciplinary specialists who care for children with congenital and acquired heart disease and adults with CHD, including pediatric and adult subspecialists in cardiology, critical care, cardiothoracic surgery, anesthesiology, hematology, general surgery, infectious diseases, and nursing. The writing group

2013 American Heart Association

52. Valvular Heart Disease: A Proposal to Optimize Care for Patients

NationalHealthService,congenital heart disease care has been redirected; 3 tiers of care, ranging from localtospecialistsurgicalcenters,havebeen organized to provide different levels of care according to patient need (44). In the United States, adult congenital heart disease centers (https://www.achaheart. org/provider-support/accreditation-program)aswellas pulmonary hypertension centers (https://phassociation. org/phcarecenters/medical-professionals/center-criteria/) have been formally designated after meeting (...) and tiered systems of care in other areas of medicine have been developed and embedded in the complex and large U.S. healthcare system. Often a key question is: what should constitute the designation of a centerwithinasystemasspecializedandcomprehensive? Examples of requirements for such a designation are available in multiple areas of medicine, both for acute problems (stroke, trauma, and myocardial infarction) and selected chronic disorders (bariatric surgery for obesity, adult congenital disease

2019 American College of Cardiology

53. Valvular Heart Disease: A Proposal to Optimize Care for Patients

NationalHealthService,congenital heart disease care has been redirected; 3 tiers of care, ranging from localtospecialistsurgicalcenters,havebeen organized to provide different levels of care according to patient need (44). In the United States, adult congenital heart disease centers (https://www.achaheart. org/provider-support/accreditation-program)aswellas pulmonary hypertension centers (https://phassociation. org/phcarecenters/medical-professionals/center-criteria/) have been formally designated after meeting (...) and tiered systems of care in other areas of medicine have been developed and embedded in the complex and large U.S. healthcare system. Often a key question is: what should constitute the designation of a centerwithinasystemasspecializedandcomprehensive? Examples of requirements for such a designation are available in multiple areas of medicine, both for acute problems (stroke, trauma, and myocardial infarction) and selected chronic disorders (bariatric surgery for obesity, adult congenital disease

2019 American College of Cardiology

54. Heart Disease and Stroke Statistics (Full text)

led to an expanding population of adult congenital heart disease patients. Although there remains increased mortality in patients with congenital cardiovascular defects compared with the general population, the standardized mortality ratios after congenital heart disease surgery continue to decrease. In a recent study from the Pediatric Cardiac Care Consortium’s US-based multicenter data registry, which examined 35 998 patients with a median follow-up of 18 years, the overall standardized (...) . Physical Inactivity e99 5. Nutrition e119 6. Overweight and Obesity e138 Health Factors and Other Risk Factors 7. High Blood Cholesterol and Other Lipids e161 8. High Blood Pressure e174 9. Diabetes Mellitus e193 10. Metabolic Syndrome e212 11. Kidney Disease e233 12. Sleep e249 Cardiovascular Conditions/Diseases 13. Total Cardiovascular Diseases e257 14. Stroke (Cerebrovascular Disease) e281 15. Congenital Cardiovascular Defects and Kawasaki Disease e327 16. Disorders of Heart Rhythm e346 17. Sudden

2019 American Heart Association PubMed abstract

55. Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management

catheterization, noninvasive imaging, and medical therapies have significantly lowered mortality rates for children and adolescents with complex congenital heart disease (CHD). , Survivors are at risk for neurodevelopmental morbidity caused by both biological and environmental risk factors. Biological risk factors include underlying syndromes or genetic/developmental disorders, the circulatory abnormalities specific to the heart defect, and the medical and surgical therapies required. Biological risk factors (...) Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies

2012 American Heart Association

56. Structural and congenital heart disease interventions: the role of three-dimensional printing (Full text)

Structural and congenital heart disease interventions: the role of three-dimensional printing Advances in catheter-based interventions in structural and congenital heart disease have mandated an increased demand for three-dimensional (3D) visualisation of complex cardiac anatomy. Despite progress in 3D imaging modalities, the pre- and periprocedural visualisation of spatial anatomy is relegated to two-dimensional flat screen representations. 3D printing is an evolving technology based (...) in the catheter-based treatment of adult patients with structural and congenital heart disease while highlighting the current limitations of this technology in terms of segmentation, model accuracy and dynamic capabilities. Furthermore, we provide information on the resources needed to establish a hospital-based 3D printing laboratory.

2017 Netherlands Heart Journal PubMed abstract

57. Acyanotic Congenital Heart Disease and Transesophageal Echocardiography (Full text)

Acyanotic Congenital Heart Disease and Transesophageal Echocardiography The spectrum of congenital heart disease (CHD) seen in the adult varies widely. Malformations range from mild anomalies requiring no intervention to extremely complex pathologies characterized by the presence of multiple coexistent defects. Echocardiography represents the primary noninvasive imaging modality in the assessment of these lesions. The transesophageal approach expands the applications of echocardiography (...) by allowing the acquisition of anatomic and functional information that may not be obtainable by transthoracic imaging.

2017 Annals of cardiac anaesthesia PubMed abstract

58. Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension. (Full text)

Multimodality imaging in congenital heart disease-related pulmonary arterial hypertension. Pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease (CHD) is associated with increased morbidity and mortality. The present review aims to discuss the clinical applications of invasive and non-invasive diagnostic modalities and to describe the strengths and weaknesses of each technique. Chest radiograph is an inexpensive investigation providing information on pulmonary (...) and pulmonary circulation, may represent an ideal target for evaluation with cardiac magnetic resonance. This non-invasive imaging modality has a low biological impact. CT plays an important role for patients with limited echocardiographic windows and those who are unable to undergo MRI (claustrophobia, poor compliance, presence of a pacemaker/implantable cardioverter defibrillator). It is the modality of choice for detailed assessment of pulmonary vessel obstruction or thrombosis. Finally, heart

2016 Heart PubMed abstract

59. Management of Valvular Heart Disease

navigation 21 September 2017 Article Contents Article Navigation 2017 ESC/EACTS Guidelines for the management of valvular heart disease Helmut Baumgartner Corresponding authors: Helmut Baumgartner, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert Schweitzer Campus 1, Building A1, 48149 Muenster, Germany. Tel: +49 251 834 6110, Fax: +49 251 834 6109, E-mail: . Volkmar Falk, Department of Cardiothoracic and Vascular Surgery (...) , German Heart Center, Augustenburger Platz 1, D-133353 Berlin, Germany and Department of Cardiovascular Surgery, Charite Berlin, Charite platz 1, D-10117 Berlin, Germany. Tel: +49 30 4593 2000, Fax: +49 30 4593 2100, E-mail: . Search for other works by this author on: Volkmar Falk Corresponding authors: Helmut Baumgartner, Division of Adult Congenital and Valvular Heart Disease, Department of Cardiovascular Medicine, University Hospital Muenster, Albert Schweitzer Campus 1, Building A1, 48149 Muenster

2017 European Society of Cardiology

60. BSG consensus guidelines on the management of inflammatory bowel disease in adults

BSG consensus guidelines on the management of inflammatory bowel disease in adults 1 Version accepted by Gut 10 th June 2019 British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults Authors Christopher A. Lamb 1,2 *, Nicholas A. Kennedy 3,4 , Tim Raine 5 , Philip Hendy 6,7 , Philip J. Smith 8 , Jimmy K. Limdi 9,10 , Bu’Hussain Hayee 11,12 , Miranda Lomer 12,13 , Gareth C. Parkes 14,15 , Christian P. Selinger 16,17 , Kevin J. Barrett 18 (...) and symptomatic burden between patients, and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing

2019 British Society of Gastroenterology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>